SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-18-251656
Filing Date
2018-08-17
Accepted
2018-08-17 16:01:59
Documents
4
Period of Report
2018-08-17
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d545412d8k.htm 8-K 20952
2 EX-5.1 d545412dex51.htm EX-5.1 10085
3 EX-10.1 d545412dex101.htm EX-10.1 200076
4 GRAPHIC g545412g52n34.jpg GRAPHIC 1724
  Complete submission text file 0001193125-18-251656.txt   234766
Mailing Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459
Business Address 85 WELLS AVENUE SECOND FLOOR NEWTON MA 02459 617-658-0600
Karyopharm Therapeutics Inc. (Filer) CIK: 0001503802 (see all company filings)

IRS No.: 263931704 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36167 | Film No.: 181025783
SIC: 2834 Pharmaceutical Preparations